Cme Group Stock Performance
CME Stock | USD 258.68 1.16 0.45% |
On a scale of 0 to 100, CME holds a performance score of 14. The firm shows a Beta (market volatility) of -0.031, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning CME are expected to decrease at a much lower rate. During the bear market, CME is likely to outperform the market. Please check CME's treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to make a quick decision on whether CME's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CME Group are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, CME exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
CME dividend paid on 27th of December 2024 | 12/27/2024 |
CME dividend paid on 16th of January 2025 | 01/16/2025 |
Begin Period Cash Flow | 93.1 B |
CME |
CME Relative Risk vs. Return Landscape
If you would invest 22,914 in CME Group on December 17, 2024 and sell it today you would earn a total of 2,954 from holding CME Group or generate 12.89% return on investment over 90 days. CME Group is generating 0.2048% of daily returns assuming volatility of 1.0855% on return distribution over 90 days investment horizon. In other words, 9% of stocks are less volatile than CME, and above 96% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
Risk |
CME Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CME's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CME Group, and traders can use it to determine the average amount a CME's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1886
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | CME | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.09 actual daily | 9 91% of assets are more volatile |
Expected Return
0.2 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average CME is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CME by adding it to a well-diversified portfolio.
CME Fundamentals Growth
CME Stock prices reflect investors' perceptions of the future prospects and financial health of CME, and CME fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CME Stock performance.
Return On Equity | 0.13 | ||||
Return On Asset | 0.0184 | ||||
Profit Margin | 0.58 % | ||||
Operating Margin | 0.63 % | ||||
Current Valuation | 93.36 B | ||||
Shares Outstanding | 359.27 M | ||||
Price To Earning | 32.83 X | ||||
Price To Book | 3.51 X | ||||
Price To Sales | 15.18 X | ||||
Revenue | 6.13 B | ||||
EBITDA | 5.04 B | ||||
Cash And Equivalents | 2.22 B | ||||
Cash Per Share | 6.19 X | ||||
Total Debt | 3.43 B | ||||
Debt To Equity | 0.12 % | ||||
Book Value Per Share | 73.66 X | ||||
Cash Flow From Operations | 3.69 B | ||||
Earnings Per Share | 9.67 X | ||||
Total Asset | 137.45 B | ||||
Retained Earnings | 4.19 B | ||||
Current Asset | 37.9 B | ||||
Current Liabilities | 36.82 B | ||||
About CME Performance
By analyzing CME's fundamental ratios, stakeholders can gain valuable insights into CME's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CME has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CME has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME operates under Financial Data Stock Exchanges classification in the United States and is traded on NASDAQ Exchange. It employs 3480 people.Things to note about CME Group performance evaluation
Checking the ongoing alerts about CME for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CME Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Over 90.0% of the company shares are held by institutions such as insurance companies |
- Analyzing CME's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CME's stock is overvalued or undervalued compared to its peers.
- Examining CME's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CME's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CME's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CME's stock. These opinions can provide insight into CME's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CME Stock analysis
When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |